BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 24461075)

  • 1. The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.
    Ghattass K; El-Sitt S; Zibara K; Rayes S; Haddadin MJ; El-Sabban M; Gali-Muhtasib H
    Mol Cancer; 2014 Jan; 13():12. PubMed ID: 24461075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21.
    El-Khatib M; Geara F; Haddadin MJ; Gali-Muhtasib H
    Radiat Oncol; 2010 Nov; 5():107. PubMed ID: 21078189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.
    Chia JS; Du JL; Hsu WB; Sun A; Chiang CP; Wang WB
    BMC Cancer; 2010 Apr; 10():175. PubMed ID: 20429953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis.
    Terzuoli E; Donnini S; Giachetti A; Iñiguez MA; Fresno M; Melillo G; Ziche M
    Clin Cancer Res; 2010 Aug; 16(16):4207-16. PubMed ID: 20682710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation.
    Gali-Muhtasib H; Sidani M; Geara F; Mona AD; Al-Hmaira J; Haddadin MJ; Zaatari G
    Int J Oncol; 2004 May; 24(5):1121-31. PubMed ID: 15067333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy-Resistant Breast Cancer Cells Enhance Tumor Progression by Enhancing Premetastatic Niche Formation through the HIF-1α-LOX Axis.
    Ko YS; Rugira T; Jin H; Joo YN; Kim HJ
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bishonokiol A inhibits breast cancer cell invasion and migration by suppressing hypoxia inducible factor-1α.
    Li HM; Miao J; Zhu M; Gao M; Dai Y; Huo Q; Ma T; Wu CZ
    J Bioenerg Biomembr; 2019 Jun; 51(3):239-248. PubMed ID: 31062127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells.
    Wang F; Zhang W; Guo L; Bao W; Jin N; Liu R; Liu P; Wang Y; Guo Q; Chen B
    Cancer Sci; 2014 Aug; 105(8):1063-70. PubMed ID: 24890366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells.
    Li Z; Zhu Q; Hu L; Chen H; Wu Z; Li D
    Cancer Sci; 2015 Aug; 106(8):1041-9. PubMed ID: 26079208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2/STAT pathways in breast cancer xenografts.
    Park JH; Darvin P; Lim EJ; Joung YH; Hong DY; Park EU; Park SH; Choi SK; Moon ES; Cho BW; Park KD; Lee HK; Kim MJ; Park DS; Chung IM; Yang YM
    PLoS One; 2012; 7(7):e40531. PubMed ID: 22792362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
    Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
    Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
    Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
    J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Q39, a novel synthetic Quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia.
    Weng Q; Wang D; Guo P; Fang L; Hu Y; He Q; Yang B
    Eur J Pharmacol; 2008 Mar; 581(3):262-9. PubMed ID: 18215659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells.
    Weng Q; Zhang J; Cao J; Xia Q; Wang D; Hu Y; Sheng R; Wu H; Zhu D; Zhu H; He Q; Yang B
    Invest New Drugs; 2011 Dec; 29(6):1177-87. PubMed ID: 20524035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diallyl trisulfides, a natural histone deacetylase inhibitor, attenuate HIF-1α synthesis, and decreases breast cancer metastasis.
    Wei Z; Shan Y; Tao L; Liu Y; Zhu Z; Liu Z; Wu Y; Chen W; Wang A; Lu Y
    Mol Carcinog; 2017 Oct; 56(10):2317-2331. PubMed ID: 28574600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors.
    Nilsson MB; Zage PE; Zeng L; Xu L; Cascone T; Wu HK; Saigal B; Zweidler-McKay PA; Heymach JV
    Oncogene; 2010 May; 29(20):2938-49. PubMed ID: 20208561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers.
    Krutilina R; Sun W; Sethuraman A; Brown M; Seagroves TN; Pfeffer LM; Ignatova T; Fan M
    Breast Cancer Res; 2014 Jul; 16(4):R78. PubMed ID: 25069832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YC-1 exerts inhibitory effects on MDA-MB-468 breast cancer cells by targeting EGFR in vitro and in vivo under normoxic condition.
    Cheng Y; Li W; Liu Y; Cheng HC; Ma J; Qiu L
    Chin J Cancer; 2012 May; 31(5):248-56. PubMed ID: 22507221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis.
    Dewangan J; Kaushik S; Rath SK; Balapure AK
    Life Sci; 2018 Jan; 193():9-19. PubMed ID: 29196053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.